A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy

Trial Profile

A Double-Blind, Placebo-Controlled, Single-Dose Evaluation of the Dexmedetomidine Transdermal System for Post-Operative Analgesia Following Bunionectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Postoperative pain
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Teikoku Pharma USA
  • Most Recent Events

    • 05 Oct 2017 Status changed from recruiting to completed.
    • 22 Aug 2017 Top-line results published in a Teikoku Pharma USA media release.
    • 05 Jun 2017 Planned End Date changed from 1 Jun 2017 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top